Literature DB >> 32805227

Misinformation Dissemination in Twitter in the COVID-19 Era.

Chayakrit Krittanawong1, Bharat Narasimhan2, Hafeez Ul Hassan Virk3, Harish Narasimhan4, Joshua Hahn5, Zhen Wang6, W H Wilson Tang7.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32805227      PMCID: PMC7426698          DOI: 10.1016/j.amjmed.2020.07.012

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
Twitter offers a potentially novel investigation line to evaluate self-perception and awareness in the context of the public health response to the coronavirus disease (COVID-19) pandemic. Studies have shown that Twitter content may provide crucial insights into the ongoing public health crisis. , However, some studies suggest that Twitter may play an important role in propagating misinformation in previous epidemics such as the Zika, Ebola, and yellow fever virus outbreaks.3, 4, 5 In the COVID-19 era, scientists and clinicians use Twitter to echo scientific evidence, especially toward an academic audience. However, in nonacademic contexts, the effect of Twitter in the COVID-19 era on public perception, whether beneficial or harmful, remains unknown. We hypothesize that there may be significant variation in signals of Twitter related to COVID-19 in nonacademic contexts. We extracted all Tweets and hashtags related to COVID-19 using keywords (e.g., “covid,” “covid-19,” “corona,” “coronavirus,” “positive,” “test,” “tested,” “feel,” “I,” “we,” “my,” “us,” “our”) between April 1, 2020, and June 1, 2020 using Twitter's application programming interface (API). Two investigators reviewed 25% of the extracted tweets to develop an initial conceptual framework. Then, three investigators reviewed an additional 25% of extracted tweets to refine an initial conceptual framework. Ultimately, we then identified the final coding framework with two investigators, and disagreements were resolved by discussion among the coauthors to establish a consensus. All analyses performed in this study relied on public, anonymized data and adhere to the terms and conditions, terms of use, and privacy policies of Twitter. Data mining was performed with R version 3.2.3 and subsequently with Python version 3.4.2. After excluding tweets due to retweeting, subject irrelevance, and academic source tweets, we analyzed 13,596 nonacademic tweets associated with COVID-19. We identified seven important categories of individuals’ attributions of COVID-19: 1) influenza vaccine could lead to positive COVID test results (11.5%); 2) the attribution of influenza deaths or cases to COVID19 (5.9%); 3) prior influenza infections could cause a positive COVID test (2.8%); 4) influencers that quoted “Flu shot leads to positive COVID test” (1.7%); 5) 5G networks could be a link to COVID-19 cases or symptoms (14.2%): 6) 5G is used to track individuals with a vaccine (5.5%); and 7) specific activities or seasonal effects causing allergies, which is not COVID-19 infection (2.8%). The rest are nonspecific tweets (Figure ),
Figure

Percentage of Tweets related to patients’ perception and attributed to COVID-19.

Percentage of Tweets related to patients’ perception and attributed to COVID-19. To our knowledge, this is the first study using Twitter to identify individuals’ self-reporting of COVID-19 perceptions and attributions in nonacademic settings. Our results demonstrate that tweets related to the COVID-19 pandemic in nonacademic settings may be a valuable sources of public health research, especially related to misinformation dissemination. Interestingly, after manual review, we found that tweets related to the COVID-19 pandemic in nonacademic contexts primarily contain unverifiable information or blatant misinformation. First, we found that several tweets contained misinformation regarding the relationship between influenza infection and COVID-19. There is no evidence suggesting that prior influenza infection may lead to a higher susceptibility of COVID-19 infection. However, it is possible that individuals with an influenza infection may be coinfected with COVID-19 concomitantly. Some small studies and case reports demonstrate the possibility of coinfection of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza A virus. , Additionally, a recent study does suggest higher rates of coinfection between SARS-CoV-2 and other respiratory pathogens. Secondly, we found that some individuals believe that having received the influenza vaccine can lead to a positive COVID test. Interestingly, a randomized controlled trial showed that children who received the trivalent inactivated influenza vaccine had an increased risk of infection from the coronaviruses sub-types NL63, HKU1, 229E, and OC43 (relative risk: 4.40; 95% confidence interval [CI]: 1.31-14.8). Additionally, another study found that coronavirus infection rates in individuals who received the influenza vaccine were significantly higher than in unvaccinated individuals (odds ratio [OR] = 1.36; 95% CI 1.14, 1.63, P < 0.01). However, those results may be partially due to various confounding variables such as pharmaceutical company sponsoring, geographic variability, climate, or immune-related ethnicity. Notwithstanding, COVID-19 is an evolving disease, and there has been no robust clinical evidence linking the influenza vaccine and SARS-CoV-2 infection. Third, misinformation regarding the possible mislabeling of influenza or allergy-related deaths or cases as a COVID-19 death or case is relatively common among nonacademic tweets. There is some evidence that asthma, mainly poorly controlled asthma, may increase the risk of virus-induced asthma exacerbations. However, there is no substantial evidence to support the claim that patients with allergies, influenza, or asthma are at an increased risk for COVID-19 infection or infection-related death. Most importantly, a recent single-center study in Wuhan, China, showed that a history of allergies might not be a risk factor for the SARS‐CoV‐2 infection. Last, we found two main categories of tweets related to the 5G COVID-19 conspiracy theory. The belief is that 5G networks and regional COVID-19 infections and outbreaks are in some way causally related. Similar to 3G and 4G networks, 5G wireless networks involve low-latency communications and essentially increase base station capacity and perceived quality of service. One online article claimed that 5G in some way accelerates or triggers the new coronavirus infection by suppressing the immune system via the transmission of radio waves. However, there is no evidence to support this claim. Additionally, this theory fails to explain as to why the SARS-CoV-2 virus is rapidly spreading in countries where no 5G networks exist. This study has certain limitations. First, we could not identify the clinical characteristics of Twitter users, such as educational status, socioeconomic status, occupation, cultural factors, or influencer level. Second, although we manually reviewed the data gathered, this research question's hypothesis might be subject to selection biases, leading to an overrepresentation of tweets containing misinformation rather than novel reports. Also, we intentionally excluded academic tweets, which may influence in nonacademic settings that we did not capture in this study. Twitter may provide an essential resource for public health research and a virtual platform for sharing academic data and research in an ever-changing COVID-19 pandemic. However, the spread of misinformation and unverifiable information are significant limitations to the use of Twitter, especially in non-academic contexts and users.
  11 in total

1.  Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.

Authors:  Jin-Jin Zhang; Xiang Dong; Yi-Yuan Cao; Ya-Dong Yuan; Yi-Bin Yang; You-Qin Yan; Cezmi A Akdis; Ya-Dong Gao
Journal:  Allergy       Date:  2020-02-27       Impact factor: 13.146

2.  Ebola, Twitter, and misinformation: a dangerous combination?

Authors:  Sunday Oluwafemi Oyeyemi; Elia Gabarron; Rolf Wynn
Journal:  BMJ       Date:  2014-10-14

3.  Yellow fever outbreaks and Twitter: Rumors and misinformation.

Authors:  Yeimer Ortiz-Martínez; Luisa F Jiménez-Arcia
Journal:  Am J Infect Control       Date:  2017-03-23       Impact factor: 2.918

Review 4.  Twitter as a Tool for Health Research: A Systematic Review.

Authors:  Lauren Sinnenberg; Alison M Buttenheim; Kevin Padrez; Christina Mancheno; Lyle Ungar; Raina M Merchant
Journal:  Am J Public Health       Date:  2016-11-17       Impact factor: 9.308

5.  Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran.

Authors:  Zohre Khodamoradi; Mohsen Moghadami; Mehrzad Lotfi
Journal:  Arch Iran Med       Date:  2020-04-01       Impact factor: 1.354

6.  Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens.

Authors:  David Kim; James Quinn; Benjamin Pinsky; Nigam H Shah; Ian Brown
Journal:  JAMA       Date:  2020-05-26       Impact factor: 56.272

7.  Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine.

Authors:  Benjamin J Cowling; Vicky J Fang; Hiroshi Nishiura; Kwok-Hung Chan; Sophia Ng; Dennis K M Ip; Susan S Chiu; Gabriel M Leung; J S Malik Peiris
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

8.  What Are People Tweeting About Zika? An Exploratory Study Concerning Its Symptoms, Treatment, Transmission, and Prevention.

Authors:  Michele Miller; Tanvi Banerjee; Roopteja Muppalla; William Romine; Amit Sheth
Journal:  JMIR Public Health Surveill       Date:  2017-06-19

9.  Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season.

Authors:  Greg G Wolff
Journal:  Vaccine       Date:  2019-10-10       Impact factor: 3.641

10.  Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2.

Authors:  Daniel J Jackson; William W Busse; Leonard B Bacharier; Meyer Kattan; George T O'Connor; Robert A Wood; Cynthia M Visness; Stephen R Durham; David Larson; Stephane Esnault; Carole Ober; Peter J Gergen; Patrice Becker; Alkis Togias; James E Gern; Mathew C Altman
Journal:  J Allergy Clin Immunol       Date:  2020-04-22       Impact factor: 10.793

View more
  5 in total

1.  Determinants of the Perceived Credibility of Rebuttals Concerning Health Misinformation.

Authors:  Yujia Sui; Bin Zhang
Journal:  Int J Environ Res Public Health       Date:  2021-02-02       Impact factor: 3.390

2.  Mandatory Vaccination Against COVID-19: Twitter Poll Analysis on Public Health Opinion.

Authors:  Valentin Ritschl; Fabian Eibensteiner; Erika Mosor; Maisa Omara; Lisa Sperl; Faisal A Nawaz; Chandragiri Siva Sai; Merisa Cenanovic; Hari Prasad Devkota; Mojca Hribersek; Ronita De; Elisabeth Klager; Eva Schaden; Maria Kletecka-Pulker; Sabine Völkl-Kernstock; Harald Willschke; Christoph Aufricht; Atanas G Atanasov; Tanja Stamm
Journal:  JMIR Form Res       Date:  2022-06-21

3.  COVID-19 in Memes: The Adaptive Response of Societies to the Pandemic?

Authors:  Piotr Skórka; Beata Grzywacz; Dawid Moroń; Magdalena Lenda
Journal:  Int J Environ Res Public Health       Date:  2022-10-10       Impact factor: 4.614

4.  The Influence of Provaping "Gatewatchers" on the Dissemination of COVID-19 Misinformation on Twitter: Analysis of Twitter Discourse Regarding Nicotine and the COVID-19 Pandemic.

Authors:  Nathan Silver; Elexis Kierstead; Ganna Kostygina; Hy Tran; Jodie Briggs; Sherry Emery; Barbara Schillo
Journal:  J Med Internet Res       Date:  2022-09-22       Impact factor: 7.076

5.  Twitter-based crowdsourcing: What kind of measures can help to end the COVID-19 pandemic faster?

Authors:  Himel Mondal; Emil D Parvanov; Rajeev K Singla; Rehab A Rayan; Faisal A Nawaz; Valentin Ritschl; Fabian Eibensteiner; Chandragiri Siva Sai; Merisa Cenanovic; Hari Prasad Devkota; Mojca Hribersek; Ronita De; Elisabeth Klager; Maria Kletecka-Pulker; Sabine Völkl-Kernstock; Garba M Khalid; Ronan Lordan; Mihnea-Alexandru Găman; Bairong Shen; Tanja Stamm; Harald Willschke; Atanas G Atanasov
Journal:  Front Med (Lausanne)       Date:  2022-09-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.